WEARABLES ARE HUGE!
The PAINKILLER Advantage: Next-Gen Bioelectric Relief
For decades, chronic pain management has forced patients into an exhausting compromise: rely on pharmaceuticals with heavy side effects, or use wearable TENS machines that require constant tethering and deliver a distracting, buzzing sensation.
Electrome’s PAINKILLER™ platform—powered by FDA-cleared BioElectronics technology—breaks this cycle by offering a smarter, continuous alternative to the current market.
The Competitive Landscape
The wearable pain market is crowded, but heavily reliant on temporary sensory distraction:
TENS & Neuromodulation (Enso, Quell, iReliev): These devices use electrical pulses to block pain signals from reaching the brain. While effective, they produce a noticeable tingling or buzzing sensation and are typically limited to 30- to 60-minute sessions.
Mechanical/Thermal (VibraCool): This approach uses intense vibration and ice to numb pain locally, which is bulky and impractical for extended everyday wear.
The PAINKILLER Narrative: Why It Wins
PAINKILLER outperforms traditional wearables by shifting the focus from temporary nerve distraction to sustained, cellular-level recovery.
Invisible, Sensation-Free Therapy: Instead of shocking or vibrating the skin to distract the nervous system, PAINKILLER utilizes Pulsed Shortwave Therapy (PSWT). It works silently and imperceptibly beneath the skin, targeting pain and reducing inflammation at the cellular level without the user feeling a thing.
True 24/7 Continuous Relief: While competitors limit wear-time, PAINKILLER is designed for uninterrupted, round-the-clock use—delivering up to 720 hours of continuous therapy. It is lightweight enough to be worn comfortably day or night, even over clothing, protecting patients from flare-ups and dramatically improving sleep quality.
The Predictive Leap (AI Integration): What truly sets Electrome apart is its evolution into an AI-native ecosystem. By connecting this clinical-grade wearable to an "AI Pain Coach," the platform bridges the gap between passive treatment and active data. It monitors real-time patient biometrics, allowing for personalized bioelectric dosing tailored to an individual's specific lifestyle and pain patterns.
By transforming a proven medical device into an intelligent, invisible, and continuous companion, Electrome successfully shifts pain management away from temporary relief and toward sustained, data-driven wellness.
The PAINKILLER Advantage: Next-Gen Bioelectric Relief
For decades, chronic pain management has forced patients into an exhausting compromise: rely on pharmaceuticals with heavy side effects, or use wearable TENS machines that require constant tethering and deliver a distracting, buzzing sensation.
Electrome’s PAINKILLER™ platform—powered by FDA-cleared BioElectronics technology—breaks this cycle by offering a smarter, continuous alternative to the current market.
The Competitive Landscape
The wearable pain market is crowded, but heavily reliant on temporary sensory distraction:
TENS & Neuromodulation (Enso, Quell, iReliev): These devices use electrical pulses to block pain signals from reaching the brain. While effective, they produce a noticeable tingling or buzzing sensation and are typically limited to 30- to 60-minute sessions.
Mechanical/Thermal (VibraCool): This approach uses intense vibration and ice to numb pain locally, which is bulky and impractical for extended everyday wear.
The PAINKILLER Narrative: Why It Wins
PAINKILLER outperforms traditional wearables by shifting the focus from temporary nerve distraction to sustained, cellular-level recovery.
Invisible, Sensation-Free Therapy: Instead of shocking or vibrating the skin to distract the nervous system, PAINKILLER utilizes Pulsed Shortwave Therapy (PSWT). It works silently and imperceptibly beneath the skin, targeting pain and reducing inflammation at the cellular level without the user feeling a thing.
True 24/7 Continuous Relief: While competitors limit wear-time, PAINKILLER is designed for uninterrupted, round-the-clock use—delivering up to 720 hours of continuous therapy. It is lightweight enough to be worn comfortably day or night, even over clothing, protecting patients from flare-ups and dramatically improving sleep quality.
The Predictive Leap (AI Integration): What truly sets Electrome apart is its evolution into an AI-native ecosystem. By connecting this clinical-grade wearable to an "AI Pain Coach," the platform bridges the gap between passive treatment and active data. It monitors real-time patient biometrics, allowing for personalized bioelectric dosing tailored to an individual's specific lifestyle and pain patterns.
By transforming a proven medical device into an intelligent, invisible, and continuous companion, Electrome successfully shifts pain management away from temporary relief and toward sustained, data-driven wellness.
2
